| Proteogenomics connects somatic mutations to signalling in breast cancer P Mertins, DR Mani, KV Ruggles, MA Gillette, KR Clauser, P Wang, ... Nature 534 (7605), 55-62, 2016 | 1540 | 2016 |
| Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography–mass spectrometry P Mertins, LC Tang, K Krug, DJ Clark, MA Gritsenko, L Chen, KR Clauser, ... Nature protocols 13 (7), 1632-1661, 2018 | 390 | 2018 |
| A curated resource for phosphosite-specific signature analysis*[S] K Krug, P Mertins, B Zhang, P Hornbeck, R Raju, R Ahmad, M Szucs, ... Molecular & cellular proteomics 18 (3), 576-593, 2019 | 213 | 2019 |
| Proteomics, post-translational modifications, and integrative analyses reveal molecular heterogeneity within medulloblastoma subgroups TC Archer, T Ehrenberger, F Mundt, MP Gold, K Krug, CK Mah, ... Cancer cell 34 (3), 396-410. e8, 2018 | 174 | 2018 |
| Fast type I interferon response protects astrocytes from flavivirus infection and virus-induced cytopathic effects R Lindqvist, F Mundt, JD Gilthorpe, S Wölfel, NO Gekara, A Kröger, ... Journal of neuroinflammation 13, 1-15, 2016 | 146 | 2016 |
| A knowledge graph to interpret clinical proteomics data A Santos, AR Colaço, AB Nielsen, L Niu, M Strauss, PE Geyer, F Coscia, ... Nature biotechnology 40 (5), 692-702, 2022 | 139 | 2022 |
| Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer HJ Johansson, BC Sanchez, F Mundt, J Forshed, A Kovacs, E Panizza, ... Nature communications 4 (1), 2175, 2013 | 74 | 2013 |
| Integrated multi-omic analysis of host-microbiota interactions in acute oak decline M Broberg, J Doonan, F Mundt, S Denman, JE McDonald Microbiome 6, 1-15, 2018 | 62 | 2018 |
| Specific syndecan-1 domains regulate mesenchymal tumor cell adhesion, motility and migration F Zong, E Fthenou, F Mundt, T Szatmári, I Kovalszky, L Szilák, D Brodin, ... PLoS One 6 (6), e14816, 2011 | 61 | 2011 |
| Mass spectrometry–based proteomics reveals potential roles of NEK9 and MAP2K4 in resistance to PI3K inhibition in triple-negative breast cancers F Mundt, S Rajput, S Li, KV Ruggles, AD Mooradian, P Mertins, ... Cancer research 78 (10), 2732-2746, 2018 | 57 | 2018 |
| Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma F Mundt, HJ Johansson, J Forshed, S Arslan, M Metintas, K Dobra, ... Molecular & Cellular Proteomics 13 (3), 701-715, 2014 | 53 | 2014 |
| Hyaluronan and N-ERC/mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesothelioma F Mundt, G Nilsonne, S Arslan, K Csürös, G Hillerdal, H Yildirim, ... PLoS One 8 (8), e72030, 2013 | 50 | 2013 |
| Novel genes and pathways modulated by syndecan-1: implications for the proliferation and cell-cycle regulation of malignant mesothelioma cells T Szatmári, F Mundt, G Heidari-Hamedani, F Zong, E Ferolla, ... PloS one 7 (10), e48091, 2012 | 48 | 2012 |
| Clinical knowledge graph integrates proteomics data into clinical decision-making A Santos, AR Colaço, AB Nielsen, L Niu, PE Geyer, F Coscia, ... bioRxiv, 2020.05. 09.084897, 2020 | 47 | 2020 |
| Diagnostic and prognostic value of soluble syndecan-1 in pleural malignancies F Mundt, G Heidari-Hamedani, G Nilsonne, M Metintas, A Hjerpe, K Dobra BioMed Research International 2014, 2014 | 39 | 2014 |
| Molecular targets and signaling pathways regulated by nuclear translocation of syndecan-1 T Szatmári, F Mundt, A Kumar-Singh, L Möbus, R Ötvös, A Hjerpe, ... BMC Cell Biology 18, 1-20, 2017 | 29 | 2017 |
| Variation in drug sensitivity of malignant mesothelioma cell lines with substantial effects of selenite and bortezomib, highlights need for individualized therapy A Szulkin, G Nilsonne, F Mundt, AM Wasik, P Souri, A Hjerpe, K Dobra PLoS One 8 (6), e65903, 2013 | 27 | 2013 |
| Phenotype-dependent apoptosis signalling in mesothelioma cells after selenite exposure G Nilsonne, E Olm, A Szulkin, F Mundt, A Stein, B Kocic, AK Rundlöf, ... Journal of Experimental & Clinical Cancer Research 28, 1-12, 2009 | 26 | 2009 |
| Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes, and normal tissues K Diamanti, M Cavalli, MJ Pereira, G Pan, C Castillejo-Lopez, C Kumar, ... Cell Reports Medicine 3 (10), 2022 | 15 | 2022 |
| A highly multiplexed quantitative phosphosite assay for biology and preclinical studies H Keshishian, ER McDonald III, F Mundt, R Melanson, K Krug, DA Porter, ... Molecular Systems Biology 17 (9), e10156, 2021 | 11 | 2021 |
Gustav NilsonneKarolinska Institutet & Stockholm UniversityBestätigte E-Mail-Adresse bei ki.se
